BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20813534)

  • 1. Synthesis, anti-fungal and 1,3-β-D-glucan synthase inhibitory activities of caffeic and quinic acid derivatives.
    Ma CM; Abe T; Komiyama T; Wang W; Hattori M; Daneshtalab M
    Bioorg Med Chem; 2010 Oct; 18(19):7009-14. PubMed ID: 20813534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, anti-HIV and anti-oxidant activities of caffeoyl 5,6-anhydroquinic acid derivatives.
    Ma CM; Kawahata T; Hattori M; Otake T; Wang L; Daneshtalab M
    Bioorg Med Chem; 2010 Jan; 18(2):863-9. PubMed ID: 20004585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAR studies of pyridazinone derivatives as novel glucan synthase inhibitors.
    Zhou G; Ting PC; Aslanian R; Cao J; Kim DW; Kuang R; Lee JF; Schwerdt J; Wu H; Herr RJ; Zych AJ; Yang J; Lam S; Wainhaus S; Black TA; McNicholas PM; Xu Y; Walker SS
    Bioorg Med Chem Lett; 2011 May; 21(10):2890-3. PubMed ID: 21489787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of novel macrocyclic antifungal peptides.
    Mulder MP; Kruijtzer JA; Breukink EJ; Kemmink J; Pieters RJ; Liskamp RM
    Bioorg Med Chem; 2011 Nov; 19(21):6505-17. PubMed ID: 21940175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of β-1,3-glucan synthase.
    Heasley BH; Pacofsky GJ; Mamai A; Liu H; Nelson K; Coti G; Peel MR; Balkovec JM; Greenlee ML; Liberator P; Meng D; Parker DL; Wilkening RR; Apgar JM; Racine F; Hsu MJ; Giacobbe RA; Kahn JN
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6811-6. PubMed ID: 22672801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of caffeic acid derivatives against Candida albicans biofilm.
    De Vita D; Friggeri L; D'Auria FD; Pandolfi F; Piccoli F; Panella S; Palamara AT; Simonetti G; Scipione L; Di Santo R; Costi R; Tortorella S
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1502-5. PubMed ID: 24582984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperazine propanol derivative as a novel antifungal targeting 1,3-beta-D-glucan synthase.
    Kondoh O; Inagaki Y; Fukuda H; Mizuguchi E; Ohya Y; Arisawa M; Shimma N; Aoki Y; Sakaitani M; Watanabe T
    Biol Pharm Bull; 2005 Nov; 28(11):2138-41. PubMed ID: 16272705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pyridobenzimidazole derivatives exhibiting antifungal activity by the inhibition of beta-1,6-glucan synthesis.
    Takeshita H; Watanabe J; Kimura Y; Kawakami K; Takahashi H; Takemura M; Kitamura A; Someya K; Nakajima R
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3893-6. PubMed ID: 20605446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antifungal activities of novel 1,3-beta-D-glucan synthase inhibitors. Part 1.
    Masubuchi K; Okada T; Kohchi M; Sakaitani M; Mizuguchi E; Shirai H; Aoki M; Watanabe T; Kondoh O; Yamazaki T; Satoh Y; Kobayashi K; Inoue T; Horii I; Shimma N
    Bioorg Med Chem Lett; 2001 Feb; 11(3):395-8. PubMed ID: 11212119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First diastereoselective synthesis of methyl caffeoyl- and feruloyl-muco-quinates.
    Jaiswal R; Dickman MH; Kuhnert N
    Org Biomol Chem; 2012 Jul; 10(27):5266-77. PubMed ID: 22678124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of 1,3-beta-glucan synthase by glycolipids from convolvulaceous species.
    Castelli MV; Cortés JC; Escalante AM; Bah M; Pereda-Miranda R; Ribas JC; Zacchino SA
    Planta Med; 2002 Aug; 68(8):739-42. PubMed ID: 12221599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of novel quinazoline-2,4-dione derivatives as chitin synthase inhibitors and antifungal agents.
    Ji Q; Yang D; Wang X; Chen C; Deng Q; Ge Z; Yuan L; Yang X; Liao F
    Bioorg Med Chem; 2014 Jul; 22(13):3405-13. PubMed ID: 24856180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of N-alkyl derivatives of 2-amino-2-deoxy-d-glucitol-6P as antifungal agents.
    Melcer A; Łacka I; Gabriel I; Wojciechowski M; Liberek B; Wiśniewski A; Milewski S
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6602-6. PubMed ID: 17920268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, anticandidal activity of N(3)-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic amide derivatives--novel inhibitors of glucosamine-6-phosphate synthase.
    Pawlak D; Stolarska M; Wojciechowski M; Andruszkiewicz R
    Eur J Med Chem; 2015 Jan; 90():577-82. PubMed ID: 25497131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical reactivity and antimicrobial activity of N-substituted maleimides.
    Salewska N; Boros-Majewska J; Lącka I; Chylińska K; Sabisz M; Milewski S; Milewska MJ
    J Enzyme Inhib Med Chem; 2012 Feb; 27(1):117-24. PubMed ID: 21612375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead optimization of a sulfonylurea-based piperazine pyridazinone series of glucan synthase inhibitors.
    Zych AJ; Lam SQ; Jenkins DM; Herr RJ; Ting PC; Lee JF; Kuang R; Wu H; Kim DW; Aslanian RG; Wainhaus S; Black TA; Cacciapuoti A; McNicholas PM; Xu Y; Walker SS
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4896-9. PubMed ID: 22687744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimization of pyridazinone series of glucan synthase inhibitors.
    Kuang R; Wu H; Ting PC; Aslanian RG; Cao J; Kim DW; Lee JF; Schwerdt J; Zhou G; Herr RJ; Zych AJ; Yang J; Lam SQ; Jenkins DM; Sakwa SA; Wainhaus S; Black TA; Cacciapuoti A; McNicholas PM; Xu Y; Walker SS
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5268-71. PubMed ID: 22818082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.
    Niimi K; Monk BC; Hirai A; Hatakenaka K; Umeyama T; Lamping E; Maki K; Tanabe K; Kamimura T; Ikeda F; Uehara Y; Kano R; Hasegawa A; Cannon RD; Niimi M
    J Antimicrob Chemother; 2010 May; 65(5):842-52. PubMed ID: 20233776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of beta-1,3-glucan synthase and its application to the screening of antifungal antibiotics].
    Zheng D; Zhang J; Song Y; Song D
    Wei Sheng Wu Xue Bao; 1996 Feb; 36(1):73-5. PubMed ID: 8762475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.